Noun:

కారణం, నివాస దేశం, మూల, ఫార్ములా, ఉత్పత్తి, ఉత్పన్నం, మొదలైనవి, విత్తనాలు,

orexin తెలుగు అర్థానికి ఉదాహరణ:

టిబెట్ వెలుపల నివసిస్తున్న టిబెటన్లు తమ నివాస దేశంలోని కేంద్రీయ టిబెట్ ప్రభుత్వం కార్యాలయంలో గ్రీన్ బుక్ అనే వ్యక్తిగత పత్రం కోసం దరఖాస్తు చేసుకోవచ్చు.

orexin's Usage Examples:

1,2,4-Trimethylbenzene dissolved in mineral oil is used as a liquid scintillator in particle physics experiments such as NOνA and Borexino.

(orektikós), ὄρεξις (órexis), ὄρεγμα (óregma) anorectic, anorexia, dysorexia, orectic, orexin, parorexia org- work Greek ὄργια (órgia) orgasm organ- organ, instrument.

Note that Borexino measured neutrinos of several energies; in this manner they have demonstrated experimentally, for the first time, the pattern of solar neutrino oscillations predicted by the theory.

"Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat".

that involve dysfunctions of the orexinergic projection system include narcolepsy, motility disorders or functional gastrointestinal disorders involving.

MINOS uses a solid plastic scintillator watched by phototubes; Borexino uses a liquid pseudocumene scintillator also watched by phototubes; and the.

a 10-fold selectivity for orexin receptor type 2, whilst orexin-A is equipotent at both receptors.

In 2014, Borexino reported a successful direct detection of neutrinos from the pp-reaction at a rate of 144±33/day, consistent with the predicted rate of 131±2/day that was expected based on the Standard Solar Model prediction that the pp-reaction generates 99% of the Sun's luminosity and their analysis of the detector's efficiency.

Orexin-A, also known as hypocretin-1, is a naturally occurring neuropeptide and orexin isoform.

It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX2, with an IC50.

Lemborexant is a dual antagonist of the orexin OX1 and OX2 receptors.

Unlike other orexin receptor antagonists, ACT-335827.

(developmental code name ACT-541468), formerly known as nemorexant, is a dual orexin receptor antagonist (DORA) which was originated by Actelion Pharmaceuticals.